Regulatory Updates
🇺🇸 FDA Page 16FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 181–192 of 382 articles
Rigel Pharmaceuticals Licenses FDA-Approved Breast Cancer Drug VEPPANU
Accelerating Drug Development: FDA's AI Clinical Trials RFI Guide
Leadership Changes at FDA: Implications for Pharma
FDA Leadership Changes: Implications for the Pharmaceutical Industry
14 New Weight Loss Drugs: Regulatory Updates and Implications
2025 Drug Approvals: Biopharma's Resilience Amidst Challenges
Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide
Biotech Stocks Facing FDA Decision in June 2026: Key Insights
FDA Eases Restrictions on Peptides: Implications for Drug Approvals
Bayer's $300M Acquisition: A Strategic Move in Ophthalmology
Top 10 Takeover Targets of 2026: Market Analysis
FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma